Published in J Virol on December 18, 2013
Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proc Natl Acad Sci U S A (2014) 1.11
Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities. Clin Liver Dis (2016) 0.84
Mapping of Functional Subdomains in Terminal Protein Domain of Hepatitis B Virus Polymerase. J Virol (2016) 0.75
Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase. Acta Crystallogr F Struct Biol Commun (2015) 0.75
Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem (2000) 11.10
Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J (1990) 9.93
Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci (2005) 9.75
NPS@: network protein sequence analysis. Trends Biochem Sci (2000) 9.68
Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature (1993) 8.62
Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus. Nature (1983) 6.96
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine (2012) 6.01
Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem (2006) 5.82
Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol (1990) 4.57
Novel mechanism for reverse transcription in hepatitis B viruses. J Virol (1993) 4.47
The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J (1988) 3.52
Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro. Antimicrob Agents Chemother (2003) 3.23
Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci U S A (1996) 2.97
Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J (1997) 2.91
Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol (1994) 2.69
Molecular interaction studies using microscale thermophoresis. Assay Drug Dev Technol (2011) 2.37
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology (2001) 2.30
Hepatitis B virus replication. World J Gastroenterol (2007) 2.30
Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J Virol (1994) 2.10
Hepatitis B viruses: reverse transcription a different way. Virus Res (2008) 2.06
Isothermal titration calorimetry of protein-protein interactions. Methods (1999) 2.03
Stimulation of the weak ATPase activity of human hsp90 by a client protein. J Mol Biol (2002) 1.98
Mechanisms for regulation of Hsp70 function by Hsp40. Cell Stress Chaperones (2003) 1.84
Deciphering drift time measurements from travelling wave ion mobility spectrometry-mass spectrometry studies. Eur J Mass Spectrom (Chichester, Eng) (2009) 1.84
Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J Virol (1995) 1.83
Hepatitis B virus genetic variability and evolution. Virus Res (2007) 1.80
Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol (2007) 1.80
Amphipols from A to Z. Annu Rev Biophys (2011) 1.75
Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J Virol (2004) 1.72
Evidence for activation of the hepatitis B virus polymerase by binding of its RNA template. J Virol (1996) 1.64
Aspects of native proteins are retained in vacuum. Curr Opin Chem Biol (2006) 1.61
Static light scattering to characterize membrane proteins in detergent solution. Methods (2008) 1.54
In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90. J Virol (2000) 1.52
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV. Bioorg Med Chem (2007) 1.51
Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J Virol (1997) 1.50
In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins. J Virol (2002) 1.49
The duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon. J Virol (1998) 1.48
Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein. J Biol Chem (2003) 1.46
Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro. J Virol (2006) 1.36
Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in the RNA template. Mol Cell Biol (1998) 1.30
Reconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coli. J Virol (2001) 1.23
Selected mutations of the duck hepatitis B virus P gene RNase H domain affect both RNA packaging and priming of minus-strand DNA synthesis. J Virol (1994) 1.22
Monitoring copopulated conformational states during protein folding events using electrospray ionization-ion mobility spectrometry-mass spectrometry. J Am Soc Mass Spectrom (2007) 1.22
Hepatitis B virus resistance to antiviral drugs: where are we going? Liver Int (2011) 1.21
Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction. J Virol (1999) 1.20
Sequence- and structure-specific determinants in the interaction between the RNA encapsidation signal and reverse transcriptase of avian hepatitis B viruses. J Virol (1997) 1.19
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. PLoS Pathog (2013) 1.18
Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology (1999) 1.17
The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication. J Virol (2010) 1.09
In vitro activity of hepatitis B virus polymerase: requirement for distinct metal ions and the viral epsilon stem-loop. J Gen Virol (1998) 1.09
Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase. J Virol (2003) 1.07
Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding. J Virol (2007) 1.06
Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350. Bioorg Med Chem Lett (2008) 1.06
Review of hepatitis B therapeutics. Clin Infect Dis (2010) 1.06
Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system. Nucleic Acids Res (2007) 1.05
Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS). PLoS One (2010) 1.05
High level expression and phosphorylation of hepatitis B virus polymerase in insect cells with recombinant baculoviruses. Virology (1993) 1.03
Well-defined nanoparticles formed by hydrophobic assembly of a short and polydisperse random terpolymer, amphipol A8-35. Langmuir (2006) 0.99
In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase. J Virol (2012) 0.99
A generalized analysis of hydrophobic and loop clusters within globular protein sequences. BMC Struct Biol (2007) 0.96
Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance. Cell Mol Life Sci (2006) 0.95
Interaction between hepatitis B virus core protein and reverse transcriptase. J Virol (2000) 0.95
Functional and structural dynamics of hepadnavirus reverse transcriptase during protein-primed initiation of reverse transcription: effects of metal ions. J Virol (2008) 0.93
Entecavir for the treatment of chronic hepatitis B virus infection. Clin Ther (2006) 0.93
A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus P protein. J Virol (2011) 0.91
Agents and strategies in development for improved management of herpes simplex virus infection and disease. Expert Opin Investig Drugs (2005) 0.90
Antiviral therapies: focus on hepatitis B reverse transcriptase. Int J Biochem Cell Biol (2012) 0.89
Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein. Proc Natl Acad Sci U S A (2013) 0.89
Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro. J Virol (2011) 0.88
Purification of Hsp90 partner proteins Hop/p60, p23, and FKBP52. Methods Enzymol (1998) 0.88
Purification of recombinant and endogenous HSP70s. Methods (2004) 0.87
An interdomain RNA binding site on the hepadnaviral polymerase that is essential for reverse transcription. Virology (2009) 0.86
Protein-primed terminal transferase activity of hepatitis B virus polymerase. J Virol (2012) 0.86
Expression of stable hepatitis B viral polymerase associated with GRP94 in E. coli. Arch Virol (2000) 0.85
Expression, purification, and characterization of an active RNase H domain of the hepatitis B viral polymerase. J Biol Chem (1996) 0.85
Conformation and stability of barley chymotrypsin inhibitor-2 (CI-2) mutants containing multiple lysine substitutions. Protein Eng (1999) 0.85
Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids. J Virol (2012) 0.85
Optimized expression from a synthetic gene of an untagged RNase H domain of human hepatitis B virus polymerase which is enzymatically active. Protein Expr Purif (2007) 0.84
The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic. Biopolymers (2004) 0.84
Expression of the active human and duck hepatitis B virus polymerases in heterologous system of Pichia methanolica. Antiviral Res (2002) 0.82
TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during protein-primed initiation of DNA synthesis in vitro. J Virol (2012) 0.81
The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry. Nat Chem Biol (2013) 0.79
Coordinated evolution of the hepatitis B virus polymerase. In Silico Biol (2012) 0.78
The helicase-primase complex as a target for effective herpesvirus antivirals. Adv Exp Med Biol (2013) 0.77
Expression and purification of a functional human hepatitis B virus polymerase. World J Gastroenterol (2010) 0.76
Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis (2009) 2.99
Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect Dis (2011) 1.98
Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci (2010) 1.92
The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. PLoS Curr (2009) 1.87
Deciphering drift time measurements from travelling wave ion mobility spectrometry-mass spectrometry studies. Eur J Mass Spectrom (Chichester, Eng) (2009) 1.84
Donor-strand exchange in chaperone-assisted pilus assembly proceeds through a concerted beta strand displacement mechanism. Mol Cell (2006) 1.81
Infectious disease: tough choices to reduce Ebola transmission. Nature (2014) 1.77
A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir Viruses (2011) 1.72
Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. J Mol Biol (2006) 1.60
A simple, RNA-mediated allosteric switch controls the pathway to formation of a T=3 viral capsid. J Mol Biol (2007) 1.54
Phi-analysis at the experimental limits: mechanism of beta-hairpin formation. J Mol Biol (2006) 1.53
Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation. Nat Struct Mol Biol (2012) 1.52
Essential epidemiological mechanisms underpinning the transmission dynamics of seasonal influenza. J R Soc Interface (2011) 1.40
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses (2011) 1.32
Elongated oligomers in beta2-microglobulin amyloid assembly revealed by ion mobility spectrometry-mass spectrometry. Proc Natl Acad Sci U S A (2010) 1.29
Monitoring copopulated conformational states during protein folding events using electrospray ionization-ion mobility spectrometry-mass spectrometry. J Am Soc Mass Spectrom (2007) 1.22
Carboxyl pK(a) values and acid denaturation of BBL. J Mol Biol (2010) 1.20
Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem (2009) 1.19
Viral genomic single-stranded RNA directs the pathway toward a T=3 capsid. J Mol Biol (2009) 1.16
Unraveling the molecular basis of subunit specificity in P pilus assembly by mass spectrometry. Proc Natl Acad Sci U S A (2008) 1.14
The impact of viral RNA on assembly pathway selection. J Mol Biol (2010) 1.13
Travel patterns in China. PLoS One (2011) 1.12
Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization. Nucleic Acids Res (2013) 1.09
Improving the realism of deterministic multi-strain models: implications for modelling influenza A. J R Soc Interface (2008) 1.06
Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors. J Am Chem Soc (2013) 1.06
Insights into virus capsid assembly from non-covalent mass spectrometry. Mass Spectrom Rev (2008) 1.03
Downhill versus barrier-limited folding of BBL 1: energetic and structural perturbation effects upon protonation of a histidine of unusually low pKa. J Mol Biol (2008) 1.03
Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. Nat Chem Biol (2011) 1.01
The opening of the SPP1 bacteriophage tail, a prevalent mechanism in Gram-positive-infecting siphophages. J Biol Chem (2011) 1.01
N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer. Protein Sci (2012) 1.01
Incorporating demographic stochasticity into multi-strain epidemic models: application to influenza A. J R Soc Interface (2009) 1.01
Separation of beta2-microglobulin conformers by high-field asymmetric waveform ion mobility spectrometry (FAIMS) coupled to electrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom (2004) 0.99
Investigating the structural properties of amyloid-like fibrils formed in vitro from beta2-microglobulin using limited proteolysis and electrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom (2006) 0.99
Unraveling lactococcal phage baseplate assembly by mass spectrometry. Mol Cell Proteomics (2011) 0.98
Donor-strand exchange in chaperone-assisted pilus assembly revealed in atomic detail by molecular dynamics. J Mol Biol (2007) 0.97
Moving towards high-resolution descriptions of the molecular interactions and structural rearrangements of the human hepatitis B core protein. J Mol Biol (2008) 0.97
Downhill versus barrier-limited folding of BBL 2: mechanistic insights from kinetics of folding monitored by independent tryptophan probes. J Mol Biol (2008) 0.96
Co-populated conformational ensembles of beta2-microglobulin uncovered quantitatively by electrospray ionization mass spectrometry. J Biol Chem (2004) 0.96
Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions. PLoS Curr (2009) 0.95
HDX-ESI-MS reveals enhanced conformational dynamics of the amyloidogenic protein beta(2)-microglobulin upon release from the MHC-1. J Am Soc Mass Spectrom (2008) 0.94
The folding mechanism of BBL: Plasticity of transition-state structure observed within an ultrafast folding protein family. J Mol Biol (2009) 0.92
Conservation of transition state structure in fast folding peripheral subunit-binding domains. J Mol Biol (2008) 0.91
Understanding quinone cofactor biogenesis in methylamine dehydrogenase through novel cofactor generation. Biochemistry (2003) 0.91
Selective protein-surface sensing using ruthenium(II) tris(bipyridine) complexes. Chemistry (2010) 0.90
Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein. Proc Natl Acad Sci U S A (2013) 0.89
5-Methylthiopentose: a new substituent on lipoarabinomannan in Mycobacterium tuberculosis. J Mol Biol (2002) 0.89
Structure and dynamics of oligomeric intermediates in β2-microglobulin self-assembly. Biophys J (2011) 0.88
The role of conformational flexibility in β2-microglobulin amyloid fibril formation at neutral pH. Rapid Commun Mass Spectrom (2012) 0.88
Control of domain swapping in bovine odorant-binding protein. Biochem J (2002) 0.88
Structural determinants of polymerization reactivity of the P pilus adaptor subunit PapF. Structure (2008) 0.88
Amphipathic polymers enable the study of functional membrane proteins in the gas phase. Anal Chem (2012) 0.88
Expanding the repertoire of amyloid polymorphs by co-polymerization of related protein precursors. J Biol Chem (2013) 0.87
Structural analysis of Bacillus subtilis SPP1 phage helicase loader protein G39P. J Biol Chem (2003) 0.86
Mechanisms of parasite-induced sex reversal in Gammarus duebeni. Int J Parasitol (2004) 0.86
Effect of sequence variation on the mechanical response of amyloid fibrils probed by steered molecular dynamics simulation. Biophys J (2012) 0.86
The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes (2002) 0.86
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses (2013) 0.85
Protein surface recognition using geometrically pure Ru(II) tris(bipyridine) derivatives. Chem Commun (Camb) (2010) 0.85
Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97. J Biol Chem (2010) 0.85
Synthesis, characterization and applications of a perdeuterated amphipol. J Membr Biol (2014) 0.84
Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions. Biochemistry (2015) 0.84
Metal-mediated formation of fibrillar ABri amyloid. J Inorg Biochem (2004) 0.83
Trifluoromethyldiazirine: an effective photo-induced cross-linking probe for exploring amyloid formation. Chem Commun (Camb) (2008) 0.83
RNA-induced conformational changes in a viral coat protein studied by hydrogen/deuterium exchange mass spectrometry. Phys Chem Chem Phys (2010) 0.82
Amphipols outperform dodecylmaltoside micelles in stabilizing membrane protein structure in the gas phase. Anal Chem (2014) 0.82
Surgical anatomy of the proximal release of the gastrocnemius: a cadaveric study. Foot Ankle Int (2009) 0.81
Second order rate constants of donor-strand exchange reveal individual amino acid residues important in determining the subunit specificity of pilus biogenesis. J Am Soc Mass Spectrom (2011) 0.81
Pattern of maternal knowledge and its implications for diarrhoea control in Southern Malawi: multilevel thresholds of change analysis. Int J Environ Res Public Health (2012) 0.81
Metals accelerate the formation and direct the structure of amyloid fibrils of NAC. J Inorg Biochem (2005) 0.81
The role of chaperone-subunit usher domain interactions in the mechanism of bacterial pilus biogenesis revealed by ESI-MS. Mol Cell Proteomics (2012) 0.81
The role of ion mobility spectrometry-mass spectrometry in the analysis of protein reference standards. Anal Chem (2013) 0.80
Insights into the consequences of co-polymerisation in the early stages of IAPP and Aβ peptide assembly from mass spectrometry. Analyst (2015) 0.79
Hydrophosphinylation of unactivated terminal alkenes catalyzed by nickel chloride. J Org Chem (2013) 0.79
Quantification of human growth hormone in serum with a labeled protein as an internal standard: essential considerations. Anal Chem (2014) 0.79
Cytokine Spatzle binds to the Drosophila immunoreceptor Toll with a neurotrophin-like specificity and couples receptor activation. Proc Natl Acad Sci U S A (2013) 0.79
Analysis of amyloid nanostructures using photo-cross-linking: in situ comparison of three widely used photo-cross-linkers. ACS Chem Biol (2014) 0.79
Defining topological features of membrane proteins by nanoelectrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom (2010) 0.79
The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry. Nat Chem Biol (2013) 0.79
On the quaternary association of the type III secretion system HrcQB-C protein: experimental evidence differentiates among the various oligomerization models. J Struct Biol (2009) 0.79
Using ion mobility spectrometry-mass spectrometry to decipher the conformational and assembly characteristics of the hepatitis B capsid protein. Biophys J (2013) 0.78
Engineering a two-helix bundle protein for folding studies. Protein Eng Des Sel (2010) 0.78
Real-time measurement of myosin-nucleotide noncovalent complexes by electrospray ionization mass spectrometry. Biophys J (2007) 0.78
Considering the advantages and pitfalls of the use of isotopically labeled protein standards for accurate protein quantification. Bioanalysis (2011) 0.78
Probing bunyavirus N protein oligomerisation using mass spectrometry. Rapid Commun Mass Spectrom (2014) 0.77
Sounds lively! Choirs: introducing singing into healthcare. J R Soc Promot Health (2008) 0.77
Determination of testosterone and epitestosterone glucuronides in urine by ultra performance liquid chromatography-ion mobility-mass spectrometry. Analyst (2011) 0.77
A sequential assignment procedure for proteins that have intermediate line widths in MAS NMR spectra: amyloid fibrils of human CA150.WW2. Chembiochem (2008) 0.77
Covalent cross-linking within supramolecular peptide structures. Anal Chem (2012) 0.77
De novo sequencing of short interfering ribonucleic acids facilitated by use of tandem mass spectrometry with ion mobility spectrometry. Rapid Commun Mass Spectrom (2013) 0.76
Protein destabilisation by ruthenium(II) tris-bipyridine based protein-surface mimetics. Org Biomol Chem (2013) 0.76
Scanning conformational space with a library of stereo- and regiochemically diverse aminoglycoside derivatives: the discovery of new ligands for RNA hairpin sequences. Org Biomol Chem (2007) 0.76
Molecular dynamics simulations of mechanical failure in polymorphic arrangements of amyloid fibrils containing structural defects. Beilstein J Nanotechnol (2013) 0.75
Cardiac tamponade due to ingested gastric foreign body. Emerg Med J (2007) 0.75
Near-infrared autofluorescence spectroscopy of in vivo soft tissue sarcomas. Opt Lett (2015) 0.75
Insights into the role of the beta-2 microglobulin D-strand in amyloid propensity revealed by mass spectrometry. Mol Biosyst (2013) 0.75
The use of electrospray mass spectrometry to determine speciation in a dynamic combinatorial library for anion recognition. Chemistry (2012) 0.75
The degradation of Abeta(25-35) by the serine protease plasmin is inhibited by aluminium. J Alzheimers Dis (2002) 0.75